Edition:
United Kingdom

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

8.84USD
4:50pm GMT
Change (% chg)

$-0.02 (-0.23%)
Prev Close
$8.86
Open
$8.87
Day's High
$8.87
Day's Low
$8.84
Volume
441
Avg. Vol
2,330
52-wk High
$9.25
52-wk Low
$5.00

Summary

Name Age Since Current Position

David Tomsche

59 2013 Independent Chairman of the Board

Michael Brigham

54 2000 President, Chief Executive Officer, Treasurer, Secretary, Director

Elizabeth Williams

2016 Vice President - Manufacturing Operations

Paul Wainman

50 2014 Director

David Cunningham

49 2011 Independent Director

Jonathan Rothschild

61 2001 Independent Director

Biographies

Name Description

David Tomsche

Dr. David S. Tomsche, D.V.M., is an Independent Chairman of the Board of ImmuCell Corp. He served on the Audit Committee from February 25, 2014 through March 31, 2014. He is a large animal veterinarian and owner of Leedstone Inc. (formerly Stearns Veterinary Outlet, Inc., an animal health distribution and milking system installation company) and of J-t Enterprises of Melrose, Inc., an exporter of ImmuCell products. He served as a director of VetPharm, Inc., an animal health products distributor, from 1995 until the company was sold in 2007. He also is a dairy producer. He obtained his degrees from the University of Minnesota.

Michael Brigham

Mr. Michael F. Brigham is the President, Chief Executive Officer, Treasurer, Secretary, Director of ImmuCell Corp. He previously had been elected Vice President of the Company in December 1998 and had served as Chief Financial Officer since October 1991. He has served as Secretary since December 1995 and as Treasurer since October 1991. Prior to that, he served as Director of Finance and Administration since originally joining the Company in September 1989. Mr. Brigham has been a member of the Board of Directors of the United Way of York County since 2011, serving as its Treasurer. Mr. Brigham served as the Treasurer of the Board of Trustees of the Kennebunk Free Library from 2005 to 2011. He re-joined the Finance Committee of the library in 2012. Prior to joining the Company, he was employed as an audit manager for the public accounting firm of Ernst & Young. Mr. Brigham earned his Masters in Business Administration from New York University in 1989.

Elizabeth Williams

Ms. Elizabeth L. Williams is Vice President - Manufacturing Operations of the company. She brings extensive experience from a successful career with Zoetis and Pfizer Animal Health in a broad range of leadership roles including quality, validation, process and product development, manufacturing and site leadership at multiple locations. Most recently, she led the U.S. Region for Zoetis as Vice President, Global Manufacturing and Supply. Her breadth of expertise includes building and expanding biopharmaceutical facilities, qualifying and launching new products and processes, and leading the manufacturing and support functions at sites regulated by the USDA, FDA and other international regulatory authorities. She earned her Masters of Business Administration from Rockhurst University in Kansas City, Missouri and her Bachelor's degree in Biology from the University of Missouri.

Paul Wainman

Mr. Paul R. Wainman has been appointed as Director of ImmuCell Corp. He is a Business Strategy and Financial Consultant specializing in the paper and greeting card industry. Prior to this, he was President of Kleinfeld Paper of Billerica, MA, a personalized wedding stationery company, from September 2013 until April 2015. From 2005 to 2012, he was President and CEO of William Arthur, Inc., a division of Hallmark Cards, located in Kennebunk, ME where he led a 275-employee manufacturer of luxury stationery products. Prior to that, he served another division of Hallmark Cards as CFO and COO from 1998 to 2004. Mr. Wainman serves as a member of the Board of Directors of the Education Foundation of the Kennebunks and Arundel. He obtained a degree in Accounting and Financial Control from Sheffield City University in England and qualified as a Chartered Accountant of England and Wales in 1990.

David Cunningham

Mr. David S. Cunningham serves as an Independent Director of ImmuCell Corp., since September 07, 2011. He has been Chief Operating Officer of Axxiom Consulting LLC (which firm has no direct or indirect material interest in the transactions of Axxiom LLC, which firm has been engaged to provide consulting services to the Company) since January 2013. He was President and CEO of Teva Animal Health from May 2009 through December 2012. He was Vice President of Agri Laboratories, Ltd. of St Joseph, MO from 2003 to November 2008. Prior to that, he held several management related positions with Boehringer Ingelheim Vetmedica, Inc. and Hoechst-Roussel Agri-Vet from 1990 to 2003.

Jonathan Rothschild

Mr. Jonathan E. Rothschild is an Independent Director of ImmuCell Corp. Since 1981, he has been President and CEO of Arterio, Inc., of Concord, California, a vitamin and supplement company that does business as Ecological Formulas. Mr. Rothschild served on the Board of Directors of CCA Industries, Inc. of East Rutherford, New Jersey (a developer and marketer of health and beauty products) from August 2012 through December 2014. He also serves as a director of the Anne Frank Center USA, a not-for-profit organization. He served as a director and Chief Financial Officer of Cistron Biotechnology from 1999 until it was acquired by Celltech, PLC in November 2000.

Basic Compensation